SVRA · Savara Inc
$5.49
-0.09 (-1.61%)
At close · Aug 20
Market Cap
$1.11B
Shares
205.46M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.49
Open$5.52
Day$5.26–5.59
52W close$3.05–6.94
Avg vol 30d1.6M
Short int36.8M · 17.9% float · 20.1d
Short vol80%
Last earningsAug 6, 2020
DataJan 2020–Aug 2026
Filing10-Q · Aug 11
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 11, 2026
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−0%
below
Price vs 50-day avg
−3%
below
RSI (14)
48
neutral
MACD trend
Negative
52-week position
63%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−5%
trailing
6-month return
−9%
trailing
YTD return
−9%
this year
Relative strength
−20%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $6 — 50d above 200d
Institutional flow
Distributing
-3% holders QoQ · +25 funds added
Insider flow
Distributing
Net -$2.2M over 90 days · 100% sells
Short interest
Rising
17.92% of float · ▲ +7.8% MoM · 20.1 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
181 holders — mid 3-yr range
Squeeze score
76
high risk · 0–100
Fundamentals
Revenue growth
−100%
Y/Y
EPS growth
−10%
Y/Y
Free cash flow
$-101.1M
Balance sheet
$3.3M
net cash
Quant / Vol
risk profile
Volatility
54%
annualized · 1-yr
Max drawdown
−32%
past year
ATR
5.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−0%
Neutral
Price vs 50-day avg
−3%
Neutral
RSI (14)
48
Neutral
MACD trend
Negative
Bearish
52-week position
63%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $6 › 200d $6 — 50d above 200d
Institutional flow
Distributing
-3% holders QoQ · +25 funds added
Insider flow
Distributing
Net -$2.2M over 90 days · 100% sells
Short interest
Rising
17.92% of float · ▲ +7.8% MoM · 20.1 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
181 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $3
Now $5 · 63%
Range high $7
vs 200-day avg 0%
vs 50-day avg -3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SVRA
this stock
Savara Inc
|
$1.11B | -9.0% | -100.0% | — | 17.9% |
|
ONC
BeOne Medicines Ltd.
|
$557.05B | +21.5% | +22179.2% | 856.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$136.93B | +19.2% | +46.2% | 31.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$86.39B | +7.1% | +20.8% | 20.8 | 3.3% |
|
MRNA
Moderna, Inc.
|
$69.62B | +352.1% | +4.3% | — | 12.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SVRA | +4.2% | -4.5% | -8.8% | +0.6% | -9.0% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | +6.1% | -7.8% | -20.0% | -1.5% | -20.8% |
Key facts
CIK
1160308
CUSIP
805111101
13F (30d)
186 filings
174 filers
Visit website
Investor relations